영국의 일반 외과용 기기 : 시장 점유율 분석, 산업 동향, 통계, 성장 예측(2025-2030년)

The United Kingdom General Surgical Devices Market size is estimated at USD 0.85 billion in 2025, and is expected to reach USD 1.23 billion by 2030, at a CAGR of 7.63% during the forecast period (2025-2030).

Growth is anchored in the National Health Service (NHS) pivot toward minimally invasive and day-case surgery, the rapid approval of 11 robotic systems by the National Institute for Health and Care Excellence (NICE), and sustained demand for data-rich surgical analytics despite capital budget headwinds. A rising trauma and chronic-disease burden, especially among an aging population, accelerates orthopedic and cardiovascular procedures, while carbon-footprint-linked procurement criteria advantage suppliers of reusable or low-waste instruments. Regulatory transitions to UKCA marking create short-term uncertainty, but phased implementation mitigates immediate supply shocks and favors incumbents with strong compliance infrastructure.

United Kingdom General Surgical Devices Market Trends and Insights

Rising demand for minimally invasive devices

Robotic and laparoscopic platforms continue to displace open techniques, with Portsmouth's Queen Alexandra Hospital converting all keyhole day-case procedures to Da Vinci systems and cutting length of stay for eligible patients. The Versius Surgical Registry recorded only 5.4% conversions in 2,083 procedures, underscoring reliability and surgeon acceptance. Paediatric adoption is growing after Southampton Children's Hospital performed the UK's first robotic kidney surgery in children. Integration of analytics modules, such as Versius Clinical Insights, supplies real-time benchmarks that shorten learning curves for new users.

Increasing prevalence of trauma & chronic diseases

Elective-care recovery plans highlight orthopedic robotics: Barking, Havering and Redbridge (BHR) Hospitals logged 100 robotic joint replacements by mid-2024 with the Mako robot, citing accuracy gains and faster mobilisation. Negative-pressure wound therapy systems like PICO Single Use are scaling for complex wounds, lowering infection incidence and length of stay. The geko neuromuscular stimulator improved venous-leg-ulcer healing probability by 68%, offering 15% cost offsets on long-term wound care. Collectively, these dynamics lift procedure volumes and diversify device demand across hospitals.

Stringent MDR/UKCA regulatory timelines

Brexit-driven divergence requires UKCA marking for new devices from 2028, while transitional relief permits CE-marked products until then. Manufacturers must create incident-report data feeds conforming to new schemas by June 2025, elevating compliance costs. Overseas firms must appoint UK Responsible Persons, adding logistical layers and delaying launch timelines.

Other drivers and restraints analyzed in the detailed report include:

1. NHS long-term plan to cut inpatient stay via day-case surgery
2. Shift to single-use instruments to mitigate hospital-acquired-infection risk
3. Capital-budget headwinds in NHS trusts

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Handheld Devices generated 33.16% of 2024 revenue within the UK general surgical devices market. The UK general surgical devices market size for this segment equated to USD 0.28 billion in 2024 and is projected to advance at 6.3% CAGR through 2030. Hospitals favour their portability and cross-specialty utility, which maximises usage rates versus capital-intensive robots. Wound Closure Devices, led by bioabsorbable electro-stimulation sutures, will climb fastest at 8.81% CAGR, backed by evidence of accelerated healing and lower infection risk.

Continuous innovation sustains demand for electrosurgical pencils, laparoscopic graspers and access trocars. Standardised procedure packs promoted by NHS Supply Chain strengthen procurement of bundled device kits that reduce set-up time and logistics complexity. Domestic producers are responding to import competition with quality-assured European steel and value-added servicing.

Minimally Invasive Surgery accounted for 73.43% of the UK general surgical devices market share in 2024; it is forecast to rise at an 8.52% CAGR, reflecting the NHS's strategic commitment to procedures that reduce patient trauma, accelerate recovery, and optimize resource utilization. Implementation of minimally invasive mitral valve surgery in novice centers demonstrated comparable outcomes to conventional approaches while achieving significant reductions in hospital stays from 7 to 5 days.

Open Surgery maintains relevance for complex cases requiring direct visualization and tactile feedback, representing the remaining market share with steady demand in trauma, emergency, and specialized procedures. The procedural shift toward minimally invasive approaches is creating training requirements for surgical teams, with AI-driven education systems demonstrating improved skill acquisition and retention in laparoscopic techniques.

The United Kingdom General Surgical Devices Market Report is Segmented by Product (Handheld Devices, Laparoscopic Devices, Electrosurgical Devices, Wound Closure Devices, and More), Procedure Approach (Open Surgery, and Minimally Invasive Surgery), Application (Gynecology and Urology, Cardiology, and More) and End User (Hospitals, Ambulatory Surgical Centres and More). The Market Forecasts are Provided in Terms of Value (USD).

List of Companies Covered in this Report:

1. B. Braun
2. Medtronic
3. Olympus
4. Integra LifeSciences
5. Stryker
6. Johnson & Johnson
7. Erbe Elektromedizin
8. Boston Scientific
9. Smiths Group
10. Getinge
11. ConvaTec Group plc
12. Zimmer Biomet
13. Becton Dickinson & Co.
14. Cook Group
15. CMR Surgical Ltd.
16. Purple Surgical
17. Teleflex
18. Surgical Holdings Ltd.
19. Swann-Morton Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising demand for minimally-invasive devices
  • 4.2.2 Increasing prevalence of trauma & chronic diseases
  • 4.2.3 NHS long-term plan to cut inpatient stay via day-case surgery
  • 4.2.4 Shift to single-use instruments to mitigate hospital-acquired-infection risk
  • 4.2.5 OR digitalisation enabling device-level data analytics
  • 4.2.6 Carbon-footprint-linked procurement scoring in NHS supply chain
• 4.3 Market Restraints
  • 4.3.1 Stringent MDR/UKCA regulatory timelines
  • 4.3.2 Capital-budget headwinds in NHS trusts
  • 4.3.3 Supply chain vulnerabilities
  • 4.3.4 Surgeons' skills gap for advanced robotics
• 4.4 Regulatory Landscape
• 4.5 Technological Outlook
• 4.6 Porter's Five Forces Analysis
  • 4.6.1 Threat of New Entrants
  • 4.6.2 Bargaining Power of Buyers
  • 4.6.3 Bargaining Power of Suppliers
  • 4.6.4 Threat of Substitutes
  • 4.6.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value)

• 5.1 By Product
  • 5.1.1 Handheld Devices
  • 5.1.2 Laparoscopic Devices
  • 5.1.3 Electrosurgical Devices
  • 5.1.4 Wound Closure Devices
  • 5.1.5 Trocars and Access Devices
  • 5.1.6 Other Products
• 5.2 By Procedure Approach
  • 5.2.1 Open Surgery
  • 5.2.2 Minimally Invasive Surgery
• 5.3 By Application
  • 5.3.1 Gynecology and Urology
  • 5.3.2 Cardiology
  • 5.3.3 Orthopedic
  • 5.3.4 Neurology
  • 5.3.5 Other Applications
• 5.4 By End User
  • 5.4.1 Hospitals
  • 5.4.2 Ambulatory Surgical Centres
  • 5.4.3 Other End Users

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 B. Braun SE
  • 6.3.2 Medtronic plc
  • 6.3.3 Olympus Corporation
  • 6.3.4 Integra LifeSciences
  • 6.3.5 Stryker Corporation
  • 6.3.6 Johnson & Johnson (Ethicon)
  • 6.3.7 Erbe Elektromedizin GmbH
  • 6.3.8 Boston Scientific Corporation
  • 6.3.9 Smith & Nephew plc
  • 6.3.10 Getinge AB
  • 6.3.11 ConvaTec Group plc
  • 6.3.12 Zimmer Biomet Holdings Inc.
  • 6.3.13 Becton Dickinson & Co.
  • 6.3.14 Cook Medical
  • 6.3.15 CMR Surgical Ltd.
  • 6.3.16 Purple Surgical
  • 6.3.17 Teleflex Incorporated
  • 6.3.18 Surgical Holdings Ltd.
  • 6.3.19 Swann-Morton Ltd.

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment